指南与共识免疫规划慢病防控与筛查卫生政策与健康促进

瑞士两家三级中心儿童癌症患者对国家疫苗接种指南的依从性:回顾性研究

Adherence to national vaccination guidelines among pediatric cancer patients: a retrospective study from two tertiary care centers in Switzerland.
指南 / 共识 · Vaccine · 2026-01-22

治疗期间推荐疫苗 uptake 低(肺炎球菌结合疫苗5%、流感疫苗10%、COVID-19疫苗19%),治疗后延迟且不足(0-3个月内0-41%,之后15-76%),29%发生疫苗可预防疾病。

要点

  • 治疗期间推荐疫苗接种率低:肺炎球菌5%、流感10%、COVID-19 19%。
  • 治疗后接种延迟且不足,0-3个月内仅0-41%,之后15-76%。
  • 29%患者发生疫苗可预防疾病,多数疫苗经初级保健接种。

核心结论

  • 在治疗后疫苗接种完全依赖初级保健且无结构化院内措施的情况下,儿童癌症患者疫苗 uptake 不足。
  • 需要针对性策略提高指南依从性并减少疫苗可预防疾病负担,尤其年长儿童。

研究设计与样本

  • 采用描述性分析评估诊断时、治疗期间及治疗后疫苗 uptake,探索性分析评估接种不足危险因素。

主要发现

  • 治疗期间推荐疫苗 uptake 低:肺炎球菌结合疫苗5%、流感疫苗10%、COVID-19疫苗19%。
  • 治疗后疫苗 uptake 延迟且不足,推荐日期后0-3个月内为0-41%,之后为15-76%,因疫苗而异。
  • 诊断时年龄较小与治疗后疫苗完全接种相关(p=0.03)。
  • 30/105例(29%)发生疫苗可预防疾病,包括COVID-19、流感、水痘、带状疱疹和百日咳。
  • 治疗期间82%疫苗及治疗后100%疫苗在初级保健机构接种。

临床怎么用

  • 需关注儿童癌症患者治疗期间及治疗后疫苗接种,尤其年长儿童。
  • 应建立结构化措施改善指南依从性,减少疫苗可预防疾病负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Childhood cancer diagnosis and treatment cause significant immunosuppression, increasing vulnerability to vaccine-preventable diseases and disrupting routine vaccination schedules. In Switzerland, vaccination guidelines to support physicians caring for these patients were published in 2022. Adherence to these recommendations among pediatric cancer patients remains unknown. METHODS: We conducted a retrospective chart review of pediatric cancer patients (0-16 years at diagnosis) treated at two Swiss tertiary care centers between June 2022 and November 2024. Vaccine uptake was assessed at diagnosis, during, and after treatment using descriptive analyses. Exploratory analyses evaluated risk factors for under-vaccination, and occurrence of vaccine-preventable diseases was documented. RESULTS: Among 105 participants (median age at diagnosis 7.6 years [IQR 2.7-12.9]), uptake of vaccines recommended during treatment was low (pneumococcal conjugate vaccine 5%, influenza vaccine 10%, COVID-19 vaccine 19%). Post-treatment vaccine uptake was delayed and insufficient, ranging from 0 to 41% within 0-3 months following recommendation date and from 15 to 76% thereafter, depending on the vaccine. Younger age at diagnosis was associated with complete post-treatment vaccine uptake (p = 0.03). Vaccine-preventable diseases, including COVID-19, influenza, varicella, herpes zoster, and pertussis, occurred in 30/105 participants (29%). Most vaccines during (82%), and all vaccines after treatment (100%), were administered in primary care. CONCLUSION: In a setting where post-treatment vaccination relies exclusively on primary care and no structured in-hospital measures are set in place, vaccine uptake among pediatric cancer patients remained insufficient. Targeted strategies are needed to improve guidelines adherence and reduce the burden of vaccine-preventable diseases, particularly among older children.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Barbey FA, Otth M, Kroiss S, et al. Adherence to national vaccination guidelines among pediatric cancer patients: a retrospective study from two tertiary care centers in Switzerland. Vaccine. 2026. PMID: 41570445. doi:10.1016/j.vaccine.2026.128265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。